HealthDeveloping
FDA expects to finish abortion pill safety review in March 2027
By Mantle News
Coverage spectrum
Covered by 7 outlets across the spectrum.
7 articles in total. The spectrum counts each outlet once and leaves opinion out. How we measure bias
In a court filing Wednesday, the Food and Drug Administration said it expects to finish its safety review of the abortion pill mifepristone in March 2027, with study results expected by mid-December. The filing was made in a Louisiana lawsuit that seeks to overturn mail-order access to the drug, according to NBC News. The FDA said it will not impose new restrictions before the review is complete, according to The Hill. Anti-abortion groups criticized the timeline, according to Just the News and the Associated Press. The review will compare mifepristone’s safety with surgical abortion through 10 weeks of pregnancy, according to NBC News.
Headline and summary written by Mantle’s AI from the coverage below, under published rules. How this works
What happened
Key points
Each point shows who reports it, from Far Left to Far Right.
The FDA said it expects to complete its mifepristone safety review in March 2027.
Reported byLeft3Center1Far Right1See the outletsHide the outlets
- Left
- NBC News, ABC News, CBS News
- Center
- The Hill
- Far Right
- Just the News
The FDA said results from its study are expected in mid-December, with a final report to follow.
One side only: the leftReported byLeft3See the outletsHide the outlets
- Left
- NBC News, ABC News, CBS News
The FDA said it will not impose new restrictions on mifepristone before the review is published.
One outletThe Hill· Center
The review will compare mifepristone’s safety with surgical abortion through 10 weeks and track side effects among about 100,000 women.
One outletNBC News· Left
Anti-abortion groups criticized the timeline, and some said the review omits relevant data sources.
Reported byLeft2Far Right1See the outletsHide the outlets
- Left
- ABC News, CBS News
- Far Right
- Just the News
The FDA’s update was ordered in a Louisiana lawsuit seeking to overturn mail-order access to mifepristone.
Reported byLeft1Far Right2See the outletsHide the outlets
- Left
- NBC News
- Far Right
- The Daily Signal, Just the News
What is contested
Where accounts differ
Points the coverage does not agree on, and who says what.
The FDA’s review is a credible, gold-standard safety study.
Just the News reports that Health Secretary Robert F. Kennedy Jr. promised a gold-standard study; pro-life groups call the review a sham that misses key data, and Charlotte Lozier Institute researchers say the FDA’s 2021 decision relied on deeply flawed evidence.
The FDA will leave mifepristone unrestricted until the review is done.
The FDA said in its filing that it will not impose new restrictions before then, according to The Hill; a CatholicVote official quoted by the Daily Signal said nothing is expected to happen until after the elections.
How each side tells it
Compare views
the left
3 outlets
Left-side headlines are neutral and attribute the timeline to the FDA: NBC News reports the March completion date in its own headline, while ABC News repeats an Associated Press report and CBS News wrote its own headline on the same report.
FDA says it will complete safety review of abortion pill in March
NBC NewsLeftAll left-leaning headlines the center
1 outlet
The Hill’s headline is a timing statement, FDA: mifepristone review won’t be done until March, while its description says the filing is likely to anger anti-abortion activists, the only center article in the input.
FDA: mifepristone review won't be done until March
The HillCenterAll center headlines the right
3 outlets
All three right-side outlets are rated Far Right and wrote their own headlines, which are more pointed than the other sides: the Daily Wire presents the 2021 decision as having opened floodgates on flawed evidence, the Daily Signal calls the drug deadly and expects little from the update, and Just the News calls the review a sham.
'Fool's gold': Pro-life groups Loaded verb“trash”“Trash” expresses contempt, where “criticize” reports the same reaction without judgement.More neutral: criticizeDisagree with this highlight? FDA abortion pill safety review as sham after details Loaded verb“exposed”“Exposed” implies details were hidden and uncovered, which the headline does not establish.More neutral: reportedDisagree with this highlight?
Just the NewsFar RightAll right-leaning headlines
The words they chose
Language to notice
Words that carry a judgement beyond the facts. Tap a highlighted word anywhere on the page to see why.
Left1
condemned
Center1
revelations
Right4
floodgatesDeadly Drugtrashexposed
In the outlets’ own words
Sensational language
floodgatesMore neutral: expanded access
“Floodgates” implies uncontrolled flooding, a picture the reporting does not establish.
A decision from the Food and Drug Administration that opened up the floodgates of mail-order abortions relied on deeply flawed evidence, a group of researchers…
Used byThe Daily Wire (Far Right)
Loaded modifier
Deadly DrugMore neutral: abortion pill
“Deadly” is a judgement about a drug the FDA approved and is still reviewing, and a neutral name was available.
FDA Must Update Court on Deadly Drug.
Used byThe Daily Signal (Far Right)
Loaded verb
trashMore neutral: criticize
“Trash” expresses contempt, where “criticize” reports the same reaction without judgement.
'Fool's gold': Pro-life groups trash FDA abortion pill safety review as sham after details exposed
Used byJust the News (Far Right)
Loaded verb
exposedMore neutral: reported
“Exposed” implies details were hidden and uncovered, which the headline does not establish.
…gold': Pro-life groups trash FDA abortion pill safety review as sham after details exposed
Used byJust the News (Far Right)
Show 2 more phrasesShow fewer
Sensational language
revelationsMore neutral: disclosures
“Revelations” implies hidden information was uncovered, while the filing was a routine court disclosure.
The revelations are likely to further anger anti-abortion activists, who have been losing patience…
Used byThe Hill (Center)
Loaded verb
condemnedMore neutral: criticized
“Condemned” conveys moral judgement, where “criticized” reports the same response.
…main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug's use curtailed.
Used byABC News (Left)
See for yourself
Side by side
What each side leads with and what it leaves out. Open a side to read its headlines.
From the left
3 outletsLeads with
- the FDA’s stated March completion timeline
- mid-December study results
- study design comparing mifepristone with surgical abortion
See the 3 headlines from the leftHide the headlines
FDA says its review of abortion pill will continue into next year
The Food and Drug Administration says its ongoing safety review of the nation’s main abortion pill will continue into next year
Also published by CBS News. It counts once.
- NBC NewsLeft
FDA says it will complete safety review of abortion pill in March
A federal judge in Louisiana ordered the agency to provide an update on its safety study as part of a lawsuit seeking to overturn a provision allowing mifepristone to be delivered by mail.
FDA says its abortion pill safety review will continue into next year
CBS News published a report that is shown in full at ABC News. The headline is the one CBS News gave it.
From the center
1 outletLeads with
- the FDA’s no-new-restrictions position
- anti-abortion anger at the timeline
- the March completion date
Leaves out
- mid-December expected study results
- the Louisiana lawsuit behind the filing
Reported by other sides, not found in this side’s coverage.
See the headline from the centerHide the headlines
- The HillCenter
FDA: mifepristone review won't be done until March
The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it won’t impose any new restrictions on the pill before that point. …
From the right
3 outletsLeads with
- the FDA’s 2021 decision and the evidence behind it
- low expectations for the FDA update before the midterms
- pro-life groups rejecting the review as a sham
Leaves out
- hundreds of peer-reviewed studies finding mifepristone safe
- the FDA’s planned comparison with surgical abortion
Reported by other sides, not found in this side’s coverage.
See the 3 headlines from the rightHide the headlines
- Just the NewsFar Right
'Fool's gold': Pro-life groups Loaded verb“trash”“Trash” expresses contempt, where “criticize” reports the same reaction without judgement.More neutral: criticizeDisagree with this highlight? FDA abortion pill safety review as sham after details Loaded verb“exposed”“Exposed” implies details were hidden and uncovered, which the headline does not establish.More neutral: reportedDisagree with this highlight?
Pro-life disillusionment with President Trump's second-term record worsens GOP voter enthusiasm gap going into the midterms. "Gold-standard" safety review promised by RFK Jr. faulted for missing relevant data sources.
- The Daily SignalFar Right
FDA Must Update Court on Loaded modifier“Deadly Drug”“Deadly” is a judgement about a drug the FDA approved and is still reviewing, and a neutral name was available.More neutral: abortion pillDisagree with this highlight?. Critics Have Low Expectations.
The pro-life movement has low expectations ahead of the deadline for the Food and Drug Administration to provide an update on its abortion pill safety review, leaders tell the Daily Signal. …
- The Daily WireFar Right
Inside The Government Decision That Opened Up Abortion Pill Sensational language“Floodgates”“Floodgates” implies uncontrolled flooding, a picture the reporting does not establish.More neutral: expanded accessDisagree with this highlight?
A decision from the Food and Drug Administration that opened up the Sensational language“floodgates”“Floodgates” implies uncontrolled flooding, a picture the reporting does not establish.More neutral: expanded accessDisagree with this highlight? of mail-order abortions relied on deeply flawed evidence, a group of researchers found. …
Articles you open from here build My Mix, a private picture of how your reading spreads across the spectrum, kept on this device. What is My Mix?
The left is Far Left and Left together. The right is Right and Far Right together. Every outlet keeps its own five-point rating.
Who reported it when
How the coverage built up
Left
1 day 14 hr later
Its first report, Oct 7, 9:29 PM EDT
Center
1 day 15 hr later
Its first report, Oct 7, 10:33 PM EDT
Right
First to report
The Daily Wire, Oct 6, 6:55 AM EDT
See the order the outlets reported inHide the order
- The Daily WireFar RightOct 6, 6:55 AM EDT
- The Daily SignalFar RightOct 6, 5:10 PM EDT
- NBC NewsLeftOct 7, 9:29 PM EDT
- The HillCenterOct 7, 10:33 PM EDT
- ABC NewsLeftOct 7, 11:50 PM EDT
- CBS NewsLeftOct 8, 6:30 AM EDT
Times are the ones the outlets published in their own feeds, in Eastern time. Opinion is left out. Just the News gave only a date, so it is not placed.
Read next
More on Health
HealthBreaking
Federal officials withhold $1.2 billion in Medicaid funding from California
4 outlets
More on Health
HealthDeveloping
Pope Leo’s doctors say he needs no further treatment after lung cancer surgery
15 outlets
Next in today’s stories
WorldDeveloping
Witkoff meets Putin in St. Petersburg; Kremlin says it is ready for three-way talks
17 outlets
Next in today’s stories
WorldBreaking
Russia frees US citizen Stephen Hubbard during US envoy Witkoff’s visit
33 outlets
A story one side mostly skipped
PoliticsBreaking
Polling firm Wedgewood admits its midterm polls were fabricated
14 outletsQuiet on the left